Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05701358 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

Study acronym: COMPLETE-2
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 28 to 113v5
  2. Study sites: 1 to 28v4
  3. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Primary and study completion dates: Mar 2028 to Jun 2028 · Start date changed from estimate of Jul 2023 to Jun 22, 2023v3 Show 3 more changesShow less
    • Study sites: 0 to 1
    • Primary and study completion dates: Mar 2028 to Jun 2028
    • Start date changed from estimate of Jul 2023 to Jun 22, 2023
  4. Start date: Mar 2023 to Jul 2023v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
COMPLETE-2 is a prospective, multi-centre, randomized controlled trial comparing a strategy of physiology-guided complete revascularization to angiography-guided complete revascularization in patients with acute ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI) and multivessel coronary artery disease (CAD) who have undergone successful culprit lesion Percutaneous Coronary Intervention (PCI). COMPLETE-2 OCT is a large scale, prospective, multi-centre, observational, imaging study of patients with STEMI or NSTEMI and multivessel CAD in a subset of eligible COMPLETE-2 patients.
Trial Details
NCT Number NCT05701358
Lead Sponsor Population Health Research Institute
Conditions Acute Myocardial Infarction, Coronary Artery Disease
Enrollment 5,100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov